Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz
Right arrow CME: Take the course for this article:
Volume 70, Number 24, June 10, 2008
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kreisl, T. N.
Right arrow Articles by DeAngelis, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreisl, T. N.
Right arrow Articles by DeAngelis, L. M.
NEUROLOGY 2008;70:2314-2320
© 2008 American Academy of Neurology

Ischemic stroke in patients with primary brain tumors

Teri N. Kreisl, MD, Thomas Toothaker, MD, Sasan Karimi, MD and Lisa M. DeAngelis, MD

From Memorial Sloan-Kettering Cancer Center (T.N.K., S.K., L.M.D.) and New York Presbyterian Hospital–Weill Cornell Medical Center (T.T.), New York, NY.

Address correspondence and reprint requests to Dr. Lisa M. DeAngelis, Chairman, Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021 deangell{at}mskcc.org.

Background: Primary brain tumor patients are at increased risk for stroke from disease and treatment-specific mechanisms.

Methods: We conducted a retrospective review of patients with primary brain tumors diagnosed with MRI-confirmed ischemic stroke between 1996 and 2006. Data were collected including risk factors, diagnostic workup, and treatment for stroke. Modified Rankin Scale (MRS) scores at stroke diagnosis were determined, and stroke etiology was assigned using Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria for nonpostoperative strokes.

Results: Sixty-eight cases of confirmed ischemic stroke in 66 patients (56% men) were analyzed. The median age at time of stroke was 60 years. The distribution of stroke risk factors was comparable to the general stroke population. The most common brain tumors were gliomas, 60%; meningiomas, 25%; and primary CNS lymphoma, 6%. Stroke was the initial clinical diagnosis in only 43% of cases. The distribution of stroke etiology was operative complication, 49%; cardioembolic, 12%; small vessel lacune, 12%; large vessel, 6%; other, 15%; and undetermined, 7%. Seventeen patients (25%) had strokes related to delayed effects of radiation. The median latency from radiation to stroke diagnosis was 3.2 years. Therapy for secondary prevention of stroke was added in one-half of patients. Median survival from the time of stroke was 1.7 years and was correlated with MRS scores.

Conclusions: Treatment complications from surgery and radiotherapy account for the majority of ischemic strokes in patients with primary brain tumors. Stroke is often a missed diagnosis that can contribute additional neurologic disability in an already susceptible patient population.

Abbreviations: ADC = apparent diffusion coefficient; CAD = coronary artery disease; DVT = deep venous thrombosis; DWI = diffusion-weighted imaging; MR = magnetic resonance; MRS = Modified Rankin Scale; MSKCC = Memorial Sloan-Kettering Cancer Center; NBTE = nonbacterial thrombotic endocarditis; OS = overall survival; PE = pulmonary embolus; PVD = peripheral vascular disease; RT = radiation therapy; TOAST = Trial of Org 10172 in Acute Stroke Treatment.


Disclosure: The authors report no disclosures.

Received July 26, 2007. Accepted in final form March 4, 2008.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by AAN Enterprises, Inc.